Table 3.
Grade 1/2 | Grade 3 | Grade 4 | |
---|---|---|---|
Hematologic toxicity | |||
Anemia | 2 (3.6) | 1 (1.8) | |
Leukopenia | 2 (3.6) | ||
Neutropenia | 3 (5.5) | 2 (3.6) | |
Thrombocytopenia | 2 (3.6) | ||
Gastrointestinal toxicity | |||
Anorexia | 1 (1.8) | ||
Diarrhea | 22 (40.0) | 2 (3.6) | |
Nausea | 8 (14.5) | ||
Vomiting | 1 (1.8) | ||
Constipation | 4 (7.3) | ||
Rectal tenesmus | 1 (1.8) | ||
Rectal bleeding | 2 (3.6) | ||
Rectal/anal pain | 8 (14.5) | ||
General toxicity | |||
Asthenia | 8 (14.5) | ||
Cardiac toxicity | 1 (1.8) | ||
Erythema | 3 (5.5) | ||
Infection | 3 (5.5) | ||
Liver hepatic toxicity | 1 (1.8) | ||
Nervous system disorders | 1 (1.8) | ||
Pain | 1 (1.8) | ||
Pruritus | 1 (1.8) | ||
Skin toxicity | 2 (3.6) | 2 (3.6) | |
Stomatitis | 2 (3.6) | ||
Lipase/amylase increase | 1 (1.8) | ||
Lower urinary tract disorder | 5 (9.1) | ||
AST/ALT increase | 1 (1.8) | ||
Hypokalemia | 1 (1.8) | 1 (1.8) | |
Other | 10 (18.2) |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; SAE, serious adverse event.